Yao, Jun
Zhang, Minlu
Zhang, Xia
Zhang, Junqing
Clinical trials referenced in this document:
Documents that mention this clinical trial
Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis
https://doi.org/10.1007/s13300-023-01369-6
Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies
https://doi.org/10.1136/bmjdrc-2021-002290
Documents that mention this clinical trial
Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis
https://doi.org/10.1007/s13300-023-01369-6
Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies
https://doi.org/10.1136/bmjdrc-2021-002290
Documents that mention this clinical trial
Impact of Type 2 Diabetes Duration on the Efficacy and Safety of Add-on Lixisenatide in Asian Individuals Receiving Basal Insulin: A Pooled Analysis
https://doi.org/10.1007/s13300-023-01369-6
Lixisenatide is effective and safe as add-on treatment to basal insulin in Asian individuals with type 2 diabetes and different body mass indices: a pooled analysis of data from the GetGoal Studies
https://doi.org/10.1136/bmjdrc-2021-002290
Funding for this research was provided by:
Sanofi
Article History
Received: 19 April 2022
Accepted: 11 January 2023
First Online: 21 February 2023